Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von pablomurio 

Discuss Abbott Laboratories

Abbott Laboratories

WKN: 850103 / Symbol: ABT / Name: Abbott / Aktie / Pharmazeutika / Large Cap /

88,04 €
0,05 %

Einschätzung Buy
Rendite (%) 13,86 %
Kursziel 100,38
Veränderung
Endet am 22.06.27

Abbott Laboratories (ABT) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $115.00 price target on the stock.
Ratings data for ABT provided by MarketBeat

wow

Einschätzung Buy
Rendite (%) 9,12 %
Kursziel 106,10
Veränderung
Endet am 01.07.27

Abbott Laboratories (ABT) is now covered by Robert W. Baird. They set an "outperform" rating and a $121.00 price target on the stock.
Ratings data for ABT provided by MarketBeat

Abbott Laboratories (ABT) was upgraded by Robert W. Baird to "strong-buy".
Ratings data for ABT provided by MarketBeat

Thanks for sharing such an amazing information https://egybestapk.org/

Einschätzung Buy
Rendite (%) 0,92 %
Kursziel 117,14
Veränderung
Endet am 17.07.27

Abbott Laboratories (ABT) had its price target raised by BTIG Research from $131.00 to $134.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,05 %
Kursziel 113,65
Veränderung
Endet am 17.07.27

Abbott Laboratories (ABT) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $130.00 price target on the stock.
Ratings data for ABT provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,47 %
Kursziel 100,53
Veränderung
Endet am 17.07.27

Abbott Laboratories (ABT) had its "buy" rating reaffirmed by TD Cowen. They now have a $115.00 price target on the stock.
Ratings data for ABT provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,74 %
Kursziel 97,91
Veränderung
Endet am 17.07.27

Abbott Laboratories (ABT) had its price target raised by Wells Fargo & Company from $109.00 to $112.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,34 %
Kursziel 104,90
Veränderung
Endet am 17.07.27

Abbott Laboratories (ABT) had its price target raised by JPMorgan Chase & Co. from $110.00 to $120.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,87 %
Kursziel 103,16
Veränderung
Endet am 17.07.27

Abbott Laboratories (ABT) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $118.00 price target on the stock, up from $115.00.
Ratings data for ABT provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,41 %
Kursziel 97,91
Veränderung
Endet am 17.07.27

Abbott Laboratories (ABT) had its price target raised by Citigroup Inc. from $108.00 to $112.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat